The Discounted Cash Flow (DCF) valuation of BELLUS Health Inc (BLU.TO) is (510,846.30) CAD. With the latest stock price at 19.48 CAD, the upside of BELLUS Health Inc based on DCF is -2622514.3%.
Based on the latest price of 19.48 CAD and our DCF valuation, BELLUS Health Inc (BLU.TO) is a sell. selling BLU.TO stocks now will result in a potential gain of 2622514.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.0% - 9.8% | 8.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,149,404.54) - (326,751.94) | (510,846.30) |
| Upside | -5900534.0% - -1677471.4% | -2622514.3% |